Q2 2024 EPS Estimates for Stevanato Group S.p.A. Decreased by Analyst (NYSE:STVN)

Stevanato Group S.p.A. (NYSE:STVN) – William Blair cut their Q2 2024 earnings estimates for Stevanato Group in a research report issued on Thursday, May 9th. William Blair analyst M. Larew now forecasts that the company will post earnings of $0.11 per share for the quarter, down from their prior forecast of $0.15. The consensus estimate for Stevanato Group’s current full-year earnings is $0.55 per share. William Blair also issued estimates for Stevanato Group’s Q3 2024 earnings at $0.15 EPS, FY2024 earnings at $0.56 EPS, Q1 2025 earnings at $0.13 EPS, Q2 2025 earnings at $0.14 EPS, Q3 2025 earnings at $0.17 EPS and Q4 2025 earnings at $0.23 EPS.

Stevanato Group (NYSE:STVN) last posted its quarterly earnings data on Thursday, May 9th. The company reported €0.09 ($0.10) earnings per share (EPS) for the quarter, missing the consensus estimate of €0.12 ($0.13) by (€0.03) (($0.03)). The company had revenue of €256.24 million for the quarter, compared to the consensus estimate of €261.28 million. Stevanato Group had a return on equity of 13.28% and a net margin of 12.57%.

Other equities analysts have also issued reports about the stock. Stephens restated an “overweight” rating and issued a $38.00 price objective on shares of Stevanato Group in a report on Monday, March 25th. BNP Paribas assumed coverage on Stevanato Group in a research report on Monday, April 22nd. They set an “outperform” rating for the company. Finally, Morgan Stanley reissued an “equal weight” rating and issued a $30.00 price target on shares of Stevanato Group in a report on Monday, April 22nd. Two analysts have rated the stock with a hold rating and five have given a buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of €34.29 ($36.87).

Stevanato Group Stock Up 3.4 %

Shares of STVN stock opened at €21.82 ($23.46) on Monday. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.50 and a quick ratio of 1.06. Stevanato Group has a 12-month low of €20.01 ($21.52) and a 12-month high of €36.30 ($39.03). The firm has a 50-day moving average price of €28.91 and a 200 day moving average price of €28.87.

Institutional Trading of Stevanato Group

Hedge funds have recently made changes to their positions in the company. Lindenwold Advisors INC acquired a new position in shares of Stevanato Group in the 1st quarter worth approximately $324,000. Jackson Square Partners LLC lifted its holdings in Stevanato Group by 763.9% in the first quarter. Jackson Square Partners LLC now owns 1,824,240 shares of the company’s stock valued at $58,558,000 after buying an additional 1,613,075 shares during the period. William Blair Investment Management LLC boosted its position in Stevanato Group by 50.1% during the first quarter. William Blair Investment Management LLC now owns 1,432,868 shares of the company’s stock valued at $45,995,000 after acquiring an additional 478,260 shares during the last quarter. Russell Investments Group Ltd. grew its holdings in Stevanato Group by 10.8% during the 1st quarter. Russell Investments Group Ltd. now owns 78,317 shares of the company’s stock worth $2,514,000 after acquiring an additional 7,615 shares during the period. Finally, Comgest Global Investors S.A.S. increased its holdings in Stevanato Group by 94.4% in the first quarter. Comgest Global Investors S.A.S. now owns 251,366 shares of the company’s stock worth $8,069,000 after purchasing an additional 122,057 shares in the last quarter.

About Stevanato Group

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.